Texas Instruments (TXN) 10-Q27 Oct 212021 Q3 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	9 Months Ended
Cover Page - shares	Sep. 30, 2021	Oct. 19, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	001-03761
Entity Registrant Name	TEXAS INSTRUMENTS INCORPORATED
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	75-0289970
Entity Address, Address Line One	12500 TI Boulevard
Entity Address, City or Town	Dallas
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75243
City Area Code	214
Local Phone Number	479-3773
Title of 12(b) Security	Common Stock, par value $1.00
Trading Symbol	TXN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		923,526,047
Entity Central Index Key	0000097476
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenue	$ 4,643	$ 3,817	$ 13,512	$ 10,385
Cost of revenue (COR)	1,491	1,364	4,486	3,762
Gross profit	3,152	2,453	9,026	6,623
Research and development (R&D)	388	386	1,165	1,142
Selling, general and administrative (SG&A)	412	407	1,262	1,225
Acquisition charges	47	51	142	151
Restructuring charges/other	0	0	0	24
Operating profit	2,305	1,609	6,457	4,081
Other income (expense), net (OI&E)	15	27	134	151
Interest and debt expense	45	49	135	142
Income before income taxes	2,275	1,587	6,456	4,090
Provision for income taxes	328	234	825	183
Net income	$ 1,947	$ 1,353	$ 5,631	$ 3,907
Earnings per common share (EPS):
Basic (in dollars per share)	$ 2.10	$ 1.47	$ 6.08	$ 4.22
Diluted (in dollars per share)	$ 2.07	$ 1.45	$ 5.99	$ 4.17
Average shares outstanding (millions):
Basic (in shares)	923	917	923	921
Diluted (in shares)	936	929	936	933
Diluted EPS:
Net income	$ 1,947	$ 1,353	$ 5,631	$ 3,907
Income allocated to RSUs	(9)	(6)	(24)	(19)
Income allocated to common stock for diluted EPS	$ 1,938	$ 1,347	$ 5,607	$ 3,888

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 1,947	$ 1,353	$ 5,631	$ 3,907
Net actuarial losses of defined benefit plans:
Adjustments, net of tax effect of ($1) and $3; ($8) and $4	3	(7)	24	(8)
Recognized within net income, net of tax effect of ($2) and ($2); ($7) and ($7)	8	7	24	21
Prior service credit of defined benefit plans:
Recognized within net income, net of tax effect of $0 and $0; $0 and $0	(1)	(1)	(1)	(1)
Other comprehensive income (loss), net of taxes	10	(1)	47	12
Total comprehensive income	$ 1,957	$ 1,352	$ 5,678	$ 3,919

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement of Comprehensive Income [Abstract]
Net actuarial losses of defined benefit plans adjustment, tax effect	$ (1)	$ 3	$ (8)	$ 4
Net actuarial losses of defined benefit plans recognized within net income, tax effect	(2)	(2)	(7)	(7)
Prior service credit of defined benefit plans recognized within net income, tax effect	$ 0	$ 0	$ 0	$ 0

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 5,663	$ 3,107
Short-term investments	4,119	3,461
Accounts receivable, net of allowances of ($9) and ($11)	1,653	1,414
Raw materials	224	180
Work in process	1,034	964
Finished goods	605	811
Inventories	1,863	1,955
Prepaid expenses and other current assets	287	302
Total current assets	13,585	10,239
Property, plant and equipment at cost	6,661	5,781
Accumulated depreciation	(2,640)	(2,512)
Property, plant and equipment	4,021	3,269
Goodwill	4,362	4,362
Acquisition-related intangibles	9	152
Deferred tax assets	309	343
Capitalized software licenses	88	122
Overfunded retirement plans	252	246
Other long-term assets	647	618
Total assets	23,273	19,351
Current liabilities:
Current portion of long-term debt	500	550
Accounts payable	596	415
Accrued compensation	665	767
Income taxes payable	101	134
Accrued expenses and other liabilities	551	524
Total current liabilities	2,413	2,390
Long-term debt	7,239	6,248
Underfunded retirement plans	129	131
Deferred tax liabilities	86	90
Other long-term liabilities	1,255	1,305
Total liabilities	11,122	10,164
Stockholders’ equity:
Preferred stock, $25 par value. Authorized – 10,000,000 shares; none issued	0	0
Common stock, $1 par value. Authorized - 2,400,000,000 shares, Shares issued - 1,740,815,939	1,741	1,741
Paid-in capital	2,563	2,333
Retained earnings	44,847	42,051
Treasury common stock at cost: Shares: June 30, 2021 – 817,729,258; December 31, 2020 – 821,461,787	(36,687)	(36,578)
Accumulated other comprehensive income (loss), net of taxes (AOCI)	(313)	(360)
Total stockholders’ equity	12,151	9,187
Total liabilities and stockholders’ equity	$ 23,273	$ 19,351

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Allowance for doubtful accounts receivable, current	$ 9	$ 11
Stockholders' equity:
Preferred stock, par value (in dollars per share)	$ 25	$ 25
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	2,400,000,000	2,400,000,000
Common stock, shares issued (in shares)	1,740,815,939	1,740,815,939
Treasury stock (in shares)	817,400,928	821,461,787

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities
Net income	$ 5,631	$ 3,907
Adjustments to net income:
Depreciation	555	553
Amortization of acquisition-related intangibles	142	151
Amortization of capitalized software	44	45
Stock compensation	180	182
Gains on sales of assets	(7)	(3)
Deferred taxes	19	(115)
Increase (decrease) from changes in:
Accounts receivable	(239)	(318)
Inventories	92	(71)
Prepaid expenses and other current assets	99	0
Accounts payable and accrued expenses	87	60
Accrued compensation	(103)	(48)
Income taxes payable	(54)	(316)
Changes in funded status of retirement plans	48	16
Other	(95)	(29)
Cash flows from operating activities	6,399	4,014
Cash flows from investing activities
Capital expenditures	(1,180)	(437)
Proceeds from asset sales	7	3
Purchases of short-term investments	(6,427)	(3,435)
Proceeds from short-term investments	5,770	3,958
Other	(36)	(15)
Cash flows from investing activities	(1,866)	74
Cash flows from financing activities
Proceeds from issuance of long-term debt	1,495	1,498
Repayment of debt	(550)	(500)
Dividends paid	(2,824)	(2,489)
Stock repurchases	(385)	(2,538)
Proceeds from common stock transactions	325	356
Other	(38)	(30)
Cash flows from financing activities	(1,977)	(3,703)
Net change in cash and cash equivalents	2,556	385
Cash and cash equivalents at beginning of period	3,107	2,437
Cash and cash equivalents at end of period	$ 5,663	$ 2,822

Description of business, includ

Description of business, including segment and geographic area information	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Description of business, including segment and geographic area information	Description of business, including segment and geographic area information We design, make and sell semiconductors to electronics designers and manufacturers all over the world. We have two reportable segments, Analog and Embedded Processing, each of which represents groups of similar products that are combined on the basis of similar design and development requirements, product characteristics, manufacturing processes and distribution channels. • Analog semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. Analog semiconductors are also used to manage power in all electronic equipment by converting, distributing, storing, discharging, isolating and measuring electrical energy, whether the equipment is plugged into a wall or using a battery. Our Analog segment consists of two major product lines: Power and Signal Chain. • Embedded Processing products are the digital “brains” of many types of electronic equipment. They are designed to handle specific tasks and can be optimized for various combinations of performance, power and cost, depending on the application. We report the results of our remaining business activities in Other. Other includes operating segments that do not meet the quantitative thresholds for individually reportable segments and cannot be aggregated with other operating segments. Other includes DLP ® products, calculators and custom ASIC products. Our centralized manufacturing and support organizations, such as facilities, procurement and logistics, provide support to our operating segments, including those in Other. Costs incurred by these organizations, including depreciation, are charged to the segments on a per-unit basis. Consequently, depreciation expense is not an independently identifiable component within the segments’ results and, therefore, is not provided. Segment information For Three Months Ended For Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Revenue: Analog $ 3,548 $ 2,865 $ 10,292 $ 7,759 Embedded Processing 738 651 2,285 1,850 Other 357 301 935 776 Total revenue $ 4,643 $ 3,817 $ 13,512 $ 10,385 Operating profit: Analog $ 1,871 $ 1,320 $ 5,295 $ 3,398 Embedded Processing 282 187 881 494 Other (a) 152 102 281 189 Total operating profit $ 2,305 $ 1,609 $ 6,457 $ 4,081 (a) Includes acquisition charges and restructuring charges/other Geographic area information The following geographic area information includes revenue, based on product shipment destination. The geographic revenue information does not necessarily reflect end demand by geography because our products tend to be shipped to the locations where our customers manufacture their products. For Three Months Ended For Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Revenue: United States $ 515 $ 440 $ 1,437 $ 1,179 Asia (a) 3,082 2,555 8,933 6,756 Europe, Middle East and Africa 683 578 2,061 1,648 Japan 242 140 716 523 Rest of world 121 104 365 279 Total revenue $ 4,643 $ 3,817 $ 13,512 $ 10,385 (a) Revenue from products shipped into China was $2.5 billion and $2.2 billion in the third quarters of 2021 and 2020, respectively, and $7.3 billion and $5.7 billion in the first nine months of 2021 and 2020, respectively, which includes shipments to customers that manufacture in China and then export end products to their customers around the world, as well as distributors that transship inventory through China to service other countries.

Basis of presentation and signi

Basis of presentation and significant accounting policies and practices	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation and significant accounting policies and practices	Basis of presentation and significant accounting policies and practices Basis of presentation The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP) and on the same basis as the audited financial statements included in our annual report on Form 10-K for the year ended December 31, 2020. The Consolidated Statements of Income, Comprehensive Income and Cash Flows for the periods ended September 30, 2021 and 2020, and the Consolidated Balance Sheet as of September 30, 2021, are not audited but reflect all adjustments that are of a normal recurring nature and are necessary for a fair statement of the results of the periods shown. Certain information and note disclosures normally included in annual consolidated financial statements have been omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Because the consolidated interim financial statements do not include all of the information and notes required by GAAP for a complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in our annual report on Form 10-K for the year ended December 31, 2020. The results for the three- and nine-month periods are not necessarily indicative of a full year’s results. Significant accounting policies and practices Earnings per share (EPS) We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing non-forfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded from the calculation of income allocated to common stock. Computation and reconciliation of earnings per common share are as follows (shares in millions): For Three Months Ended September 30, 2021 2020 Net Income Shares EPS Net Income Shares EPS Basic EPS: Net income $ 1,947 $ 1,353 Income allocated to RSUs (9) (6) Income allocated to common stock $ 1,938 923 $ 2.10 $ 1,347 917 $ 1.47 Dilutive effect of stock compensation plans 13 12 Diluted EPS: Net income $ 1,947 $ 1,353 Income allocated to RSUs (9) (6) Income allocated to common stock $ 1,938 936 $ 2.07 $ 1,347 929 $ 1.45 For Nine Months Ended September 30, 2021 2020 Net Income Shares EPS Net Income Shares EPS Basic EPS: Net income $ 5,631 $ 3,907 Income allocated to RSUs (23) (19) Income allocated to common stock $ 5,608 923 $ 6.08 $ 3,888 921 $ 4.22 Dilutive effect of stock compensation plans 13 12 Diluted EPS: Net income $ 5,631 $ 3,907 Income allocated to RSUs (24) (19) Income allocated to common stock $ 5,607 936 $ 5.99 $ 3,888 933 $ 4.17 Potentially dilutive securities representing 2 million and 3 million shares of common stock that were outstanding during the third quarters of 2021 and 2020, respectively, and 3 million and 4 million shares outstanding during the first nine months of 2021 and 2020, respectively, were excluded from the computation of diluted earnings per common share during these periods because their effect would have been anti-dilutive. Derivatives and hedging We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments. We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the value of the swaps and the related deferred compensation liabilities in SG&A. In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are recognized in AOCI and amortized over the life of the related debt. The results of these derivative transactions have not been material. We do not use derivatives for speculative or trading purposes. Fair values of financial instruments The fair values of our derivative financial instruments were not material as of September 30, 2021. Our investments in cash equivalents, short-term investments and certain long-term investments, as well as our deferred compensation liabilities, are carried at fair value. The carrying values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value due to the short maturity of such instruments. As of September 30, 2021, the carrying value of long-term debt, including the current portion, was $7.74 billion, and the estimated fair value was $8.43 billion. The estimated fair value is measured using broker-dealer quotes, which are Level 2 inputs. See Note 4 for a description of fair value and the definition of Level 2 inputs.

Income taxes

Income taxes	9 Months Ended
Income taxes	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Income taxes	Income taxes Our estimated annual effective tax rate is about 14%, which does not include discrete tax items. This differs from the 21% U.S. statutory corporate tax rate due to the effect of U.S. tax benefits. Provision for income taxes is based on the following: For Three Months Ended For Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Taxes calculated using the estimated annual effective tax rate $ 337 $ 231 $ 934 $ 561 Discrete tax items (9) 3 (109) (378) Provision for income taxes $ 328 $ 234 $ 825 $ 183 Effective tax rate 14 % 15 % 13 % 4 % Our provision for income taxes for the first nine months of 2020 included a $249 million discrete tax benefit for the settlement of a depreciation-related uncertain tax position. Accrued interest of $46 million related to this uncertain tax position was reversed and included in OI&E.

Valuation of debt and equity in

Valuation of debt and equity investments and certain liabilities	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Valuation of debt and equity investments and certain liabilities	Valuation of debt and equity investments and certain liabilities Investments measured at fair value Available-for-sale debt investments, money market funds and mutual funds are stated at fair value, which is generally based on market prices or broker quotes. See Fair-value considerations below. Unrealized gains and losses from available-for-sale debt securities are recorded as an increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets and any credit losses on available-for-sale debt securities are recorded as an allowance for credit losses with an offset recognized in OI&E in our Consolidated Statements of Income. Our mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A. Other investments Our other investments include equity-method investments and non-marketable equity investments, which are not measured at fair value. These investments consist of interests in venture capital funds and other non-marketable equity securities. Gains and losses from equity-method investments are recognized in OI&E based on our ownership share of the investee’s financial results. Non-marketable equity securities are measured at cost with adjustments for observable changes in price or impairments. Gains and losses on non-marketable equity investments are recognized in OI&E. Details of our investments are as follows: September 30, 2021 December 31, 2020 Cash and Cash Equivalents Short-Term Investments Long-Term Investments Cash and Cash Equivalents Short-Term Investments Long-Term Investments Measured at fair value: Money market funds $ 2,132 $ — $ — $ 886 $ — $ — Corporate obligations 1,136 1,109 — 256 257 — U.S. government and agency securities 1,140 2,587 — 1,340 3,054 — Non-U.S. government and agency securities 385 423 — — 150 — Mutual funds — — 15 — — 18 Total 4,793 4,119 15 2,482 3,461 18 Other measurement basis: Equity-method investments — — 54 — — 27 Non-marketable equity investments — — 4 — — 4 Cash on hand 870 — — 625 — — Total $ 5,663 $ 4,119 $ 73 $ 3,107 $ 3,461 $ 49 As of September 30, 2021, and December 31, 2020, unrealized gains and losses associated with our available-for-sale investments were not material. We did not recognize any credit losses related to available-for-sale investments for the first nine months of 2021 and 2020. All of our debt securities classified as available for sale as of September 30, 2021, have maturities within one year. Proceeds from sales, redemptions and maturities of short-term available-for-sale investments were $1.32 billion and $510 million for the third quarters of 2021 and 2020, respectively, and $5.77 billion and $3.71 billion for the first nine months of 2021 and 2020, respectively. Gross realized gains and losses from these sales were not material. During the first nine months of 2020, we entered into total return swaps to economically hedge the variability of certain deferred compensation obligations to employees. As a result, we received proceeds of $253 million from the sale of investments in mutual funds that were previously being utilized to offset this exposure. Fair-value considerations We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The three-level hierarchy described below indicates the extent and level of judgment used to estimate fair-value measurements. • Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the reporting date. • Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data. We utilize a third-party data service to provide Level 2 valuations. We verify these valuations for reasonableness relative to unadjusted quotes obtained from brokers or dealers based on observable prices for similar assets in active markets. • Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models that utilize management estimates of market participant assumptions. As of September 30, 2021, and December 31, 2020, we had no Level 3 assets or liabilities. The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value. September 30, 2021 December 31, 2020 Level 1 Level 2 Total Level 1 Level 2 Total Assets: Money market funds $ 2,132 $ — $ 2,132 $ 886 $ — $ 886 Corporate obligations — 2,245 2,245 — 513 513 U.S. government and agency securities 3,326 401 3,727 4,394 — 4,394 Non-U.S. government and agency securities — 808 808 — 150 150 Mutual funds 15 — 15 18 — 18 Total assets $ 5,473 $ 3,454 $ 8,927 $ 5,298 $ 663 $ 5,961 Liabilities: Deferred compensation $ 367 $ — $ 367 $ 350 $ — $ 350 Total liabilities $ 367 $ — $ 367 $ 350 $ — $ 350

Postretirement benefit plans

Postretirement benefit plans	9 Months Ended
Postretirement benefit plans	Sep. 30, 2021
Retirement Benefits [Abstract]
Postretirement benefit plans	Postretirement benefit plans Expenses related to defined benefit and retiree health care benefit plans are as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit For Three Months Ended September 30, 2021 2020 2021 2020 2021 2020 Service cost $ 5 $ 5 $ — $ 1 $ 9 $ 9 Interest cost 8 7 3 3 9 9 Expected return on plan assets (8) (9) (2) (2) (20) (20) Recognized net actuarial loss 3 1 — — 2 4 Amortization of prior service cost (credit) — — (1) (1) — — Net periodic benefit costs 8 4 — 1 — 2 Settlement losses 4 3 — — 1 1 Total, including other postretirement losses $ 12 $ 7 $ — $ 1 $ 1 $ 3 U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit For Nine Months Ended September 30, 2021 2020 2021 2020 2021 2020 Service cost $ 16 $ 14 $ 2 $ 2 $ 27 $ 25 Interest cost 23 24 8 9 28 28 Expected return on plan assets (25) (27) (8) (8) (61) (58) Recognized net actuarial loss 11 5 — — 6 11 Amortization of prior service cost (credit) — — (1) (1) — — Net periodic benefit costs 25 16 1 2 — 6 Settlement losses 12 10 — — 2 2 Total, including other postretirement losses $ 37 $ 26 $ 1 $ 2 $ 2 $ 8

Debt and lines of credit

Debt and lines of credit	9 Months Ended
Debt and lines of credit	Sep. 30, 2021
Debt Disclosure [Abstract]
Debt and lines of credit	Debt and lines of credit Short-term borrowings We maintain a line of credit to support commercial paper borrowings, if any, and to provide additional liquidity through bank loans. As of September 30, 2021, we had a variable-rate revolving credit facility from a consortium of investment-grade banks that allows us to borrow up to $2 billion until March 2024. The interest rate on borrowings under this credit facility, if drawn, is indexed to the applicable London Interbank Offered Rate (LIBOR). As of September 30, 2021, our credit facility was undrawn, and we had no commercial paper outstanding. Long-term debt In September 2021, we issued three series of senior unsecured notes for an aggregate principal amount of $1.50 billion, consisting of: • $500 million of 1.125% notes due in 2026; • $500 million of 1.90% notes due in 2031; and • $500 million of 2.70% notes due in 2051. We incurred $10 million of issuance costs. The proceeds of the offering were $1.50 billion, net of the original issuance discounts, which will be used for general corporate purposes. In February 2021, we retired $550 million of maturing debt. Long-term debt outstanding is as follows: September 30, December 31, 2021 2020 Notes due 2021 at 2.75% $ — $ 550 Notes due 2022 at 1.85% 500 500 Notes due 2023 at 2.25% 500 500 Notes due 2024 at 2.625% 300 300 Notes due 2025 at 1.375% 750 750 Notes due 2026 at 1.125% 500 — Notes due 2027 at 2.90% 500 500 Notes due 2029 at 2.25% 750 750 Notes due 2030 at 1.75% 750 750 Notes due 2031 at 1.90% 500 — Notes due 2039 at 3.875% 750 750 Notes due 2048 at 4.15% 1,500 1,500 Notes due 2051 at 2.70% 500 — Total debt 7,800 6,850 Net unamortized discounts, premiums and issuance costs (61) (52) Total debt, including net unamortized discounts, premiums and issuance costs 7,739 6,798 Current portion of long-term debt (500) (550) Long-term debt $ 7,239 $ 6,248 Interest and debt expense was $45 million and $49 million for the third quarters of 2021 and 2020, respectively, and $135 million and $142 million for the first nine months of 2021 and 2020, respectively. This was net of the amortized discounts, premiums and issuance costs. Capitalized interest was not material.

Stockholders' equity

Stockholders' equity	9 Months Ended
Stockholders' equity	Sep. 30, 2021
Equity [Abstract]
Stockholders’ equity	Stockholders’ equity Changes in equity are as follows: Common Stock Paid-in Capital Retained Earnings Treasury Common Stock AOCI Balance, December 31, 2020 $ 1,741 $ 2,333 $ 42,051 $ (36,578) $ (360) 2021 Net income — — 1,753 — — Dividends declared and paid ($1.02 per share) — — (940) — — Common stock issued for stock-based awards — (3) — 199 — Stock repurchases — — — (100) — Stock compensation — 61 — — — Other comprehensive income (loss), net of taxes — — — — 13 Dividend equivalents on RSUs — — (4) — — Balance, March 31, 2021 1,741 2,391 42,860 (36,479) (347) Net income — — 1,931 — — Dividends declared and paid ($1.02 per share) — — (942) — — Common stock issued for stock-based awards — 25 — 29 — Stock repurchases — — — (146) — Stock compensation — 69 — — — Other comprehensive income (loss), net of taxes — — — — 24 Dividend equivalents on RSUs — — (4) — — Other — — 1 — — Balance, June 30, 2021 1,741 2,485 43,846 (36,596) (323) Net income — — 1,947 — — Dividends declared and paid ($1.02 per share) — — (942) — — Common stock issued for stock-based awards — 27 — 48 — Stock repurchases — — — (139) — Stock compensation — 50 — — — Other comprehensive income (loss), net of taxes — — — — 10 Dividend equivalents on RSUs — — (3) — — Other — 1 (1) — — Balance, September 30, 2021 $ 1,741 $ 2,563 $ 44,847 $ (36,687) $ (313) Common Stock Paid-in Capital Retained Earnings Treasury Common Stock AOCI Balance, December 31, 2019 $ 1,741 $ 2,110 $ 39,898 $ (34,495) $ (347) 2020 Net income — — 1,174 — — Dividends declared and paid ($0.90 per share) — — (841) — — Common stock issued for stock-based awards — (77) — 223 — Stock repurchases — — — (1,730) — Stock compensation — 63 — — — Other comprehensive income (loss), net of taxes — — — — 19 Dividend equivalents on RSUs — — (4) — — Balance, March 31, 2020 1,741 2,096 40,227 (36,002) (328) Net income — — 1,380 — — Dividends declared and paid ($0.90 per share) — — (823) — — Common stock issued for stock-based awards — 17 — 70 — Stock repurchases — — — (793) — Stock compensation — 69 — — — Other comprehensive income (loss), net of taxes — — — — (6) Dividend equivalents on RSUs — — (4) — — Balance, June 30, 2020 1,741 2,182 40,780 (36,725) (334) Net income — — 1,353 — — Dividends declared and paid ($0.90 per share) — — (825) — — Common stock issued for stock-based awards — 26 — 97 — Stock repurchases — — — (15) — Stock compensation — 50 — — — Other comprehensive income (loss), net of taxes — — — — (1) Dividend equivalents on RSUs — — (3) — — Other — (1) — — — Balance, September 30, 2020 $ 1,741 $ 2,257 $ 41,305 $ (36,643) $ (335)

Contingencies

Contingencies	9 Months Ended
Contingencies	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies Indemnification guarantees We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result. Warranty costs/product liabilities We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products. General We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we believe that the results of these proceedings will not have a material adverse effect on our financial condition, results of operations or liquidity.

Supplemental financial informat

Supplemental financial information	9 Months Ended
Supplemental financial information	Sep. 30, 2021
Supplemental Financial Information [Abstract]
Supplemental financial information	Supplemental financial information Property, plant and equipment at cost In October 2021, we completed our acquisition of Micron Technology’s 300-millimeter semiconductor factory in Lehi, Utah, for cash consideration of about $900 million. Details on amounts reclassified out of accumulated other comprehensive income (loss), net of taxes, to net income Our Consolidated Statements of Comprehensive Income include items that have been recognized within net income during the third quarters and first nine months of 2021 and 2020. The table below details where these transactions are recorded in our Consolidated Statements of Income. For Three Months Ended For Nine Months Ended Impact to Related Statement of Income Lines September 30, September 30, 2021 2020 2021 2020 Net actuarial losses of defined benefit plans: Recognized net actuarial loss and settlement losses (a) $ 10 $ 9 $ 31 $ 28 Decrease to OI&E Tax effect (2) (2) (7) (7) Decrease to provision for income taxes Recognized within net income, net of taxes $ 8 $ 7 $ 24 $ 21 Decrease to net income Prior service credit of defined benefit plans: Amortization of prior service credit (a) $ (1) $ (1) $ (1) $ (1) Increase to OI&E Tax effect — — — — Increase to provision for income taxes Recognized within net income, net of taxes $ (1) $ (1) $ (1) $ (1) Increase to net income (a) Detailed in Note 5. Stock compensation

Basis of presentation and sig_2

Basis of presentation and significant accounting policies and practices (Policies)	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	Basis of presentation The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP) and on the same basis as the audited financial statements included in our annual report on Form 10-K for the year ended December 31, 2020. The Consolidated Statements of Income, Comprehensive Income and Cash Flows for the periods ended September 30, 2021 and 2020, and the Consolidated Balance Sheet as of September 30, 2021, are not audited but reflect all adjustments that are of a normal recurring nature and are necessary for a fair statement of the results of the periods shown. Certain information and note disclosures normally included in annual consolidated financial statements have been omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Because the consolidated interim financial statements do not include all of the information and notes required by GAAP for a complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in our annual report on Form 10-K for the year ended December 31, 2020. The results for the three- and nine-month periods are not necessarily indicative of a full year’s results.
Earnings per share (EPS)	Earnings per share (EPS) We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing non-forfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded from the calculation of income allocated to common stock.
Derivatives and hedging	Derivatives and hedging We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments. We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the value of the swaps and the related deferred compensation liabilities in SG&A. In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are recognized in AOCI and amortized over the life of the related debt. The results of these derivative transactions have not been material. We do not use derivatives for speculative or trading purposes.
Fair values of financial instruments	Fair values of financial instruments The fair values of our derivative financial instruments were not material as of September 30, 2021. Our investments in cash equivalents, short-term investments and certain long-term investments, as well as our deferred compensation liabilities, are carried at fair value. The carrying values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value due to the short maturity of such instruments. As of September 30, 2021, the carrying value of long-term debt, including the current portion, was $7.74 billion, and the estimated fair value was $8.43 billion. The estimated fair value is measured using broker-dealer quotes, which are Level 2 inputs. See Note 4 for a description of fair value and the definition of Level 2 inputs.
Investments measured at fair value	Investments measured at fair value Available-for-sale debt investments, money market funds and mutual funds are stated at fair value, which is generally based on market prices or broker quotes. See Fair-value considerations below. Unrealized gains and losses from available-for-sale debt securities are recorded as an increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets and any credit losses on available-for-sale debt securities are recorded as an allowance for credit losses with an offset recognized in OI&E in our Consolidated Statements of Income. Our mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A. Other investments Our other investments include equity-method investments and non-marketable equity investments, which are not measured at fair value. These investments consist of interests in venture capital funds and other non-marketable equity securities. Gains and losses from equity-method investments are recognized in OI&E based on our ownership share of the investee’s financial results. Non-marketable equity securities are measured at cost with adjustments for observable changes in price or impairments. Gains and losses on non-marketable equity investments are recognized in OI&E.
Fair value considerations	Fair-value considerations We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The three-level hierarchy described below indicates the extent and level of judgment used to estimate fair-value measurements. • Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the reporting date. • Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data. We utilize a third-party data service to provide Level 2 valuations. We verify these valuations for reasonableness relative to unadjusted quotes obtained from brokers or dealers based on observable prices for similar assets in active markets. • Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models that utilize management estimates of market participant assumptions. As of September 30, 2021, and December 31, 2020, we had no Level 3 assets or liabilities.
Indemnification guarantees and warranty costs/product liabilities	Indemnification guarantees We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result. Warranty costs/product liabilities We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products.

Description of business, incl_2

Description of business, including segment and geographic area information (Tables)	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Schedule of Segment Information	For Three Months Ended For Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Revenue: Analog $ 3,548 $ 2,865 $ 10,292 $ 7,759 Embedded Processing 738 651 2,285 1,850 Other 357 301 935 776 Total revenue $ 4,643 $ 3,817 $ 13,512 $ 10,385 Operating profit: Analog $ 1,871 $ 1,320 $ 5,295 $ 3,398 Embedded Processing 282 187 881 494 Other (a) 152 102 281 189 Total operating profit $ 2,305 $ 1,609 $ 6,457 $ 4,081 (a) Includes acquisition charges and restructuring charges/other
Schedule of Geographic Area Information	Geographic area information The following geographic area information includes revenue, based on product shipment destination. The geographic revenue information does not necessarily reflect end demand by geography because our products tend to be shipped to the locations where our customers manufacture their products. For Three Months Ended For Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Revenue: United States $ 515 $ 440 $ 1,437 $ 1,179 Asia (a) 3,082 2,555 8,933 6,756 Europe, Middle East and Africa 683 578 2,061 1,648 Japan 242 140 716 523 Rest of world 121 104 365 279 Total revenue $ 4,643 $ 3,817 $ 13,512 $ 10,385 (a) Revenue from products shipped into China was $2.5 billion and $2.2 billion in the third quarters of 2021 and 2020, respectively, and $7.3 billion and $5.7 billion in the first nine months of 2021 and 2020, respectively, which includes shipments to customers that manufacture in China and then export end products to their customers around the world, as well as distributors that transship inventory through China to service other countries.

Basis of presentation and sig_3

Basis of presentation and significant accounting policies and practices (Tables)	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Earnings Per Share	Computation and reconciliation of earnings per common share are as follows (shares in millions): For Three Months Ended September 30, 2021 2020 Net Income Shares EPS Net Income Shares EPS Basic EPS: Net income $ 1,947 $ 1,353 Income allocated to RSUs (9) (6) Income allocated to common stock $ 1,938 923 $ 2.10 $ 1,347 917 $ 1.47 Dilutive effect of stock compensation plans 13 12 Diluted EPS: Net income $ 1,947 $ 1,353 Income allocated to RSUs (9) (6) Income allocated to common stock $ 1,938 936 $ 2.07 $ 1,347 929 $ 1.45 For Nine Months Ended September 30, 2021 2020 Net Income Shares EPS Net Income Shares EPS Basic EPS: Net income $ 5,631 $ 3,907 Income allocated to RSUs (23) (19) Income allocated to common stock $ 5,608 923 $ 6.08 $ 3,888 921 $ 4.22 Dilutive effect of stock compensation plans 13 12 Diluted EPS: Net income $ 5,631 $ 3,907 Income allocated to RSUs (24) (19) Income allocated to common stock $ 5,607 936 $ 5.99 $ 3,888 933 $ 4.17

Income taxes (Tables)

Income taxes (Tables)	9 Months Ended
Income taxes (Tables)	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Provision for income taxes	Provision for income taxes is based on the following: For Three Months Ended For Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Taxes calculated using the estimated annual effective tax rate $ 337 $ 231 $ 934 $ 561 Discrete tax items (9) 3 (109) (378) Provision for income taxes $ 328 $ 234 $ 825 $ 183 Effective tax rate 14 % 15 % 13 % 4 %

Valuation of debt and equity _2

Valuation of debt and equity investments and certain liabilities (Tables)	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Investments	Details of our investments are as follows: September 30, 2021 December 31, 2020 Cash and Cash Equivalents Short-Term Investments Long-Term Investments Cash and Cash Equivalents Short-Term Investments Long-Term Investments Measured at fair value: Money market funds $ 2,132 $ — $ — $ 886 $ — $ — Corporate obligations 1,136 1,109 — 256 257 — U.S. government and agency securities 1,140 2,587 — 1,340 3,054 — Non-U.S. government and agency securities 385 423 — — 150 — Mutual funds — — 15 — — 18 Total 4,793 4,119 15 2,482 3,461 18 Other measurement basis: Equity-method investments — — 54 — — 27 Non-marketable equity investments — — 4 — — 4 Cash on hand 870 — — 625 — — Total $ 5,663 $ 4,119 $ 73 $ 3,107 $ 3,461 $ 49
Assets and Liabilities Accounted for at Fair Value	The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value. September 30, 2021 December 31, 2020 Level 1 Level 2 Total Level 1 Level 2 Total Assets: Money market funds $ 2,132 $ — $ 2,132 $ 886 $ — $ 886 Corporate obligations — 2,245 2,245 — 513 513 U.S. government and agency securities 3,326 401 3,727 4,394 — 4,394 Non-U.S. government and agency securities — 808 808 — 150 150 Mutual funds 15 — 15 18 — 18 Total assets $ 5,473 $ 3,454 $ 8,927 $ 5,298 $ 663 $ 5,961 Liabilities: Deferred compensation $ 367 $ — $ 367 $ 350 $ — $ 350 Total liabilities $ 367 $ — $ 367 $ 350 $ — $ 350

Postretirement benefit plans (T

Postretirement benefit plans (Tables)	9 Months Ended
Postretirement benefit plans (Tables)	Sep. 30, 2021
Retirement Benefits [Abstract]
Expense Related to Defined Benefit and Retiree Health Care Benefit Plans	Expenses related to defined benefit and retiree health care benefit plans are as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit For Three Months Ended September 30, 2021 2020 2021 2020 2021 2020 Service cost $ 5 $ 5 $ — $ 1 $ 9 $ 9 Interest cost 8 7 3 3 9 9 Expected return on plan assets (8) (9) (2) (2) (20) (20) Recognized net actuarial loss 3 1 — — 2 4 Amortization of prior service cost (credit) — — (1) (1) — — Net periodic benefit costs 8 4 — 1 — 2 Settlement losses 4 3 — — 1 1 Total, including other postretirement losses $ 12 $ 7 $ — $ 1 $ 1 $ 3 U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit For Nine Months Ended September 30, 2021 2020 2021 2020 2021 2020 Service cost $ 16 $ 14 $ 2 $ 2 $ 27 $ 25 Interest cost 23 24 8 9 28 28 Expected return on plan assets (25) (27) (8) (8) (61) (58) Recognized net actuarial loss 11 5 — — 6 11 Amortization of prior service cost (credit) — — (1) (1) — — Net periodic benefit costs 25 16 1 2 — 6 Settlement losses 12 10 — — 2 2 Total, including other postretirement losses $ 37 $ 26 $ 1 $ 2 $ 2 $ 8

Debt and lines of credit (Table

Debt and lines of credit (Tables)	9 Months Ended
Debt and lines of credit (Tables)	Sep. 30, 2021
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	Long-term debt outstanding is as follows: September 30, December 31, 2021 2020 Notes due 2021 at 2.75% $ — $ 550 Notes due 2022 at 1.85% 500 500 Notes due 2023 at 2.25% 500 500 Notes due 2024 at 2.625% 300 300 Notes due 2025 at 1.375% 750 750 Notes due 2026 at 1.125% 500 — Notes due 2027 at 2.90% 500 500 Notes due 2029 at 2.25% 750 750 Notes due 2030 at 1.75% 750 750 Notes due 2031 at 1.90% 500 — Notes due 2039 at 3.875% 750 750 Notes due 2048 at 4.15% 1,500 1,500 Notes due 2051 at 2.70% 500 — Total debt 7,800 6,850 Net unamortized discounts, premiums and issuance costs (61) (52) Total debt, including net unamortized discounts, premiums and issuance costs 7,739 6,798 Current portion of long-term debt (500) (550) Long-term debt $ 7,239 $ 6,248

Stockholders' equity (Tables)

Stockholders' equity (Tables)	9 Months Ended
Stockholders' equity (Tables)	Sep. 30, 2021
Equity [Abstract]
Schedule of Changes in Stockholders' Equity	Changes in equity are as follows: Common Stock Paid-in Capital Retained Earnings Treasury Common Stock AOCI Balance, December 31, 2020 $ 1,741 $ 2,333 $ 42,051 $ (36,578) $ (360) 2021 Net income — — 1,753 — — Dividends declared and paid ($1.02 per share) — — (940) — — Common stock issued for stock-based awards — (3) — 199 — Stock repurchases — — — (100) — Stock compensation — 61 — — — Other comprehensive income (loss), net of taxes — — — — 13 Dividend equivalents on RSUs — — (4) — — Balance, March 31, 2021 1,741 2,391 42,860 (36,479) (347) Net income — — 1,931 — — Dividends declared and paid ($1.02 per share) — — (942) — — Common stock issued for stock-based awards — 25 — 29 — Stock repurchases — — — (146) — Stock compensation — 69 — — — Other comprehensive income (loss), net of taxes — — — — 24 Dividend equivalents on RSUs — — (4) — — Other — — 1 — — Balance, June 30, 2021 1,741 2,485 43,846 (36,596) (323) Net income — — 1,947 — — Dividends declared and paid ($1.02 per share) — — (942) — — Common stock issued for stock-based awards — 27 — 48 — Stock repurchases — — — (139) — Stock compensation — 50 — — — Other comprehensive income (loss), net of taxes — — — — 10 Dividend equivalents on RSUs — — (3) — — Other — 1 (1) — — Balance, September 30, 2021 $ 1,741 $ 2,563 $ 44,847 $ (36,687) $ (313) Common Stock Paid-in Capital Retained Earnings Treasury Common Stock AOCI Balance, December 31, 2019 $ 1,741 $ 2,110 $ 39,898 $ (34,495) $ (347) 2020 Net income — — 1,174 — — Dividends declared and paid ($0.90 per share) — — (841) — — Common stock issued for stock-based awards — (77) — 223 — Stock repurchases — — — (1,730) — Stock compensation — 63 — — — Other comprehensive income (loss), net of taxes — — — — 19 Dividend equivalents on RSUs — — (4) — — Balance, March 31, 2020 1,741 2,096 40,227 (36,002) (328) Net income — — 1,380 — — Dividends declared and paid ($0.90 per share) — — (823) — — Common stock issued for stock-based awards — 17 — 70 — Stock repurchases — — — (793) — Stock compensation — 69 — — — Other comprehensive income (loss), net of taxes — — — — (6) Dividend equivalents on RSUs — — (4) — — Balance, June 30, 2020 1,741 2,182 40,780 (36,725) (334) Net income — — 1,353 — — Dividends declared and paid ($0.90 per share) — — (825) — — Common stock issued for stock-based awards — 26 — 97 — Stock repurchases — — — (15) — Stock compensation — 50 — — — Other comprehensive income (loss), net of taxes — — — — (1) Dividend equivalents on RSUs — — (3) — — Other — (1) — — — Balance, September 30, 2020 $ 1,741 $ 2,257 $ 41,305 $ (36,643) $ (335)

Supplemental financial inform_2

Supplemental financial information (Tables)	9 Months Ended
Supplemental financial information (Tables)	Sep. 30, 2021
Supplemental Financial Information [Abstract]
Amounts Reclassified Out of AOCI to Net Income, Net of Taxes	The table below details where these transactions are recorded in our Consolidated Statements of Income. For Three Months Ended For Nine Months Ended Impact to Related Statement of Income Lines September 30, September 30, 2021 2020 2021 2020 Net actuarial losses of defined benefit plans: Recognized net actuarial loss and settlement losses (a) $ 10 $ 9 $ 31 $ 28 Decrease to OI&E Tax effect (2) (2) (7) (7) Decrease to provision for income taxes Recognized within net income, net of taxes $ 8 $ 7 $ 24 $ 21 Decrease to net income Prior service credit of defined benefit plans: Amortization of prior service credit (a) $ (1) $ (1) $ (1) $ (1) Increase to OI&E Tax effect — — — — Increase to provision for income taxes Recognized within net income, net of taxes $ (1) $ (1) $ (1) $ (1) Increase to net income (a) Detailed in Note 5.

Description of business, incl_3

Description of business, including segment and geographic area information - Additional Information (Details)	9 Months Ended
	Sep. 30, 2021reportable_segment
Segment Reporting [Abstract]
Number of reportable segments	2

Description of business, incl_4

Description of business, including segment and geographic area information - Segment Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Segment Reporting Information [Line Items]
Total revenue	$ 4,643	$ 3,817	$ 13,512	$ 10,385
Total operating profit	2,305	1,609	6,457	4,081
Analog
Segment Reporting Information [Line Items]
Total revenue	3,548	2,865	10,292	7,759
Total operating profit	1,871	1,320	5,295	3,398
Embedded Processing
Segment Reporting Information [Line Items]
Total revenue	738	651	2,285	1,850
Total operating profit	282	187	881	494
Other
Segment Reporting Information [Line Items]
Total revenue	357	301	935	776
Total operating profit	$ 152	$ 102	$ 281	$ 189

Description of business, incl_5

Description of business, including segment and geographic area information - Geographic Area Information (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Segment Reporting Information [Line Items]
Total revenue		$ 4,643	$ 3,817	$ 13,512	$ 10,385
United States
Segment Reporting Information [Line Items]
Total revenue		515	440	1,437	1,179
Asia
Segment Reporting Information [Line Items]
Total revenue	[1]	3,082	2,555	8,933	6,756
Europe, Middle East and Africa
Segment Reporting Information [Line Items]
Total revenue		683	578	2,061	1,648
Japan
Segment Reporting Information [Line Items]
Total revenue		242	140	716	523
Rest of world
Segment Reporting Information [Line Items]
Total revenue		121	104	365	279
China
Segment Reporting Information [Line Items]
Total revenue		$ 2,500	$ 2,200	$ 7,300	$ 5,700

[1]	Revenue from products shipped into China was $2.5 billion and $2.2 billion in the third quarters of 2021 and 2020, respectively, and $7.3 billion and $5.7 billion in the first nine months of 2021 and 2020, respectively, which includes shipments to customers that manufacture in China and then export end products to their customers around the world, as well as distributors that transship inventory through China to service other countries.

Basis of presentation and sig_4

Basis of presentation and significant accounting policies and practices - Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Basic EPS:
Net income	$ 1,947	$ 1,353	$ 5,631	$ 3,907
Income allocated to RSUs	(9)	(6)	(23)	(19)
Income allocated to common stock	$ 1,938	$ 1,347	$ 5,608	$ 3,888
Weighted average number of shares outstanding, basic (in shares)	923	917	923	921
Basic (in dollars per share)	$ 2.10	$ 1.47	$ 6.08	$ 4.22
Dilutive effect of stock compensation plans (in shares)	13	12	13	12
Diluted EPS:
Net income	$ 1,947	$ 1,353	$ 5,631	$ 3,907
Income allocated to RSUs	(9)	(6)	(24)	(19)
Income allocated to common stock for diluted EPS	$ 1,938	$ 1,347	$ 5,607	$ 3,888
Weighted average number of shares outstanding, diluted (in shares)	936	929	936	933
Diluted (in dollars per share)	$ 2.07	$ 1.45	$ 5.99	$ 4.17

Basis of presentation and sig_5

Basis of presentation and significant accounting policies and practices - Additional Information (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Antidilutive securities excluded from computation of earnings per share, Amount (in shares)	2	3	3	4
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, carrying value	$ 7,739		$ 7,739		$ 6,798
Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, estimated fair value	$ 8,430		$ 8,430

Income taxes - Additional Infor

Income taxes - Additional Information (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Estimated annual effective tax rate	14.00%
Statutory corporate tax rate	21.00%
Amount of tax benefit for tax settlement		$ 249
Accrued interest related to uncertain tax position		$ 46

Income taxes - Provision for In

Income taxes - Provision for Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Taxes calculated using the estimated annual effective tax rate	$ 337	$ 231	$ 934	$ 561
Discrete tax items	(9)	3	(109)	(378)
Provision for income taxes	$ 328	$ 234	$ 825	$ 183
Effective tax rate	14.00%	15.00%	13.00%	4.00%

Valuation of debt and equity _3

Valuation of debt and equity investments and certain liabilities - Investments at Fair Value (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	$ 5,663	$ 3,107
Short-Term Investments	4,119	3,461
Long-Term Investments	73	49
Measured at fair value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	4,793	2,482
Short-Term Investments	4,119	3,461
Long-Term Investments	15	18
Measured at fair value \| Available-for-sale debt securities \| Money market funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	2,132	886
Short-Term Investments	0	0
Long-Term Investments	0	0
Measured at fair value \| Available-for-sale debt securities \| Corporate obligations
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	1,136	256
Short-Term Investments	1,109	257
Long-Term Investments	0	0
Measured at fair value \| Available-for-sale debt securities \| U.S. government and agency securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	1,140	1,340
Short-Term Investments	2,587	3,054
Long-Term Investments	0	0
Measured at fair value \| Available-for-sale debt securities \| Non-U.S. government and agency securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	385	0
Short-Term Investments	423	150
Long-Term Investments	0	0
Measured at fair value \| Trading securities \| Mutual funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-Term Investments	0	0
Long-Term Investments	15	18
Other measurement basis \| Equity-method investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-Term Investments	0	0
Long-Term Investments	54	27
Other measurement basis \| Non-marketable equity investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-Term Investments	0	0
Long-Term Investments	4	4
Other measurement basis \| Cash on hand
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	870	625
Short-Term Investments	0	0
Long-Term Investments	$ 0	$ 0

Valuation of debt and equity _4

Valuation of debt and equity investments and certain liabilities - Fair Value Assets and Liabilities Measured on Recurring Basis (Details) - Recurring - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	$ 8,927	$ 5,961
Total liabilities fair value	367	350
Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities fair value	367	350
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	5,473	5,298
Total liabilities fair value	367	350
Level 1 \| Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities fair value	367	350
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	3,454	663
Total liabilities fair value	0	0
Level 2 \| Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities fair value	0	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	2,132	886
Money market funds \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	2,132	886
Money market funds \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	0	0
Corporate obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	2,245	513
Corporate obligations \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	0	0
Corporate obligations \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	2,245	513
U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	3,727	4,394
U.S. government and agency securities \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	3,326	4,394
U.S. government and agency securities \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	401	0
Non-U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	808	150
Non-U.S. government and agency securities \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	0	0
Non-U.S. government and agency securities \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	808	150
Mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	15	18
Mutual funds \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	15	18
Mutual funds \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	$ 0	$ 0

Valuation of debt and equity _5

Valuation of debt and equity investments and certain liabilities - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Credit losses related to available-for-sale investments			$ 0	$ 0
Proceeds from sales, redemptions and maturities of short-term available-for-sale investments	$ 1,320,000,000	$ 510,000,000	5,770,000,000	3,710,000,000
Proceeds from sale of short-term investments				$ 253,000,000
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities, fair value	0		0		$ 0
Assets, fair value	$ 0		$ 0		$ 0

Postretirement benefit plans -

Postretirement benefit plans - Expense Related to Defined Benefit and Retiree Health Care Benefit Plans (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
U.S. \| Defined benefit plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 5	$ 5	$ 16	$ 14
Interest cost	8	7	23	24
Expected return on plan assets	(8)	(9)	(25)	(27)
Recognized net actuarial loss	3	1	11	5
Amortization of prior service cost (credit)	0	0	0	0
Net periodic benefit costs	8	4	25	16
Settlement losses	4	3	12	10
Total, including other postretirement losses	12	7	37	26
U.S. \| Retiree health care plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	0	1	2	2
Interest cost	3	3	8	9
Expected return on plan assets	(2)	(2)	(8)	(8)
Recognized net actuarial loss	0	0	0	0
Amortization of prior service cost (credit)	(1)	(1)	(1)	(1)
Net periodic benefit costs	0	1	1	2
Settlement losses	0	0	0	0
Total, including other postretirement losses	0	1	1	2
Non-U.S. \| Defined benefit plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	9	9	27	25
Interest cost	9	9	28	28
Expected return on plan assets	(20)	(20)	(61)	(58)
Recognized net actuarial loss	2	4	6	11
Amortization of prior service cost (credit)	0	0	0	0
Net periodic benefit costs	0	2	0	6
Settlement losses	1	1	2	2
Total, including other postretirement losses	$ 1	$ 3	$ 2	$ 8

Debt and lines of credit - Addi

Debt and lines of credit - Additional Information (Details)	1 Months Ended	3 Months Ended		9 Months Ended
Debt and lines of credit - Additional Information (Details)	Feb. 28, 2021USD ($)	Sep. 30, 2021USD ($)seriesOfDebt	Sep. 30, 2020USD ($)	Sep. 30, 2021USD ($)seriesOfDebt	Sep. 30, 2020USD ($)
Debt Instrument [Line Items]
Commercial paper		$ 0		$ 0
Retirement of debt				550,000,000	$ 500,000,000
Interest and debt expense		$ 45,000,000	$ 49,000,000	$ 135,000,000	$ 142,000,000
Senior unsecured notes
Debt Instrument [Line Items]
Number of series of debt issued \| seriesOfDebt		3		3
Principal amount		$ 1,500,000,000		$ 1,500,000,000
Debt issuance costs		10,000,000		10,000,000
Notes due 2026 at 1.125%
Debt Instrument [Line Items]
Principal amount		$ 500,000,000		$ 500,000,000
Long-term debt stated interest rate (in percentage)		1.125%		1.125%
Notes due 2031 at 1.90%
Debt Instrument [Line Items]
Principal amount		$ 500,000,000		$ 500,000,000
Long-term debt stated interest rate (in percentage)		1.90%		1.90%
Notes due 2051 at 2.70%
Debt Instrument [Line Items]
Principal amount		$ 500,000,000		$ 500,000,000
Long-term debt stated interest rate (in percentage)		2.70%		2.70%
Notes due 2021 at 2.75%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)		2.75%		2.75%
Retirement of debt	$ 550,000,000
Revolving credit facility
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		$ 2,000,000,000		$ 2,000,000,000

Debt and lines of credit - Sche

Debt and lines of credit - Schedule of Long-term Debt Outstanding (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Total debt	$ 7,800	$ 6,850
Net unamortized discounts, premiums and issuance costs	(61)	(52)
Total debt, including net unamortized discounts, premiums and issuance costs	7,739	6,798
Current portion of long-term debt	(500)	(550)
Long-term debt	$ 7,239	6,248
Notes due 2021 at 2.75%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.75%
Total debt	$ 0	550
Notes due 2022 at 1.85%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.85%
Total debt	$ 500	500
Notes due 2023 at 2.25%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.25%
Total debt	$ 500	500
Notes due 2024 at 2.625%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.625%
Total debt	$ 300	300
Notes due 2025 at 1.375%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.375%
Total debt	$ 750	750
Notes due 2026 at 1.125%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.125%
Total debt	$ 500	0
Notes due 2027 at 2.90%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.90%
Total debt	$ 500	500
Notes due 2029 at 2.25%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.25%
Total debt	$ 750	750
Notes due 2030 at 1.75%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.75%
Total debt	$ 750	750
Notes due 2031 at 1.90%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.90%
Total debt	$ 500	0
Notes due 2039 at 3.875%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	3.875%
Total debt	$ 750	750
Notes due 2048 at 4.15%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.15%
Total debt	$ 1,500	1,500
Notes due 2051 at 2.70%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.70%
Total debt	$ 500	$ 0

Stockholders' equity - Schedule

Stockholders' equity - Schedule of Changes in Stockholders' Equity (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning			$ 9,187				$ 9,187
Net income	$ 1,947			$ 1,353			5,631	$ 3,907
Other comprehensive income (loss), net of taxes	10			(1)			47	12
Balance, ending	12,151						12,151
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	1,741	$ 1,741	1,741	1,741	$ 1,741	$ 1,741	1,741	1,741
Balance, ending	1,741	1,741	1,741	1,741	1,741	1,741	1,741	1,741
Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	2,485	2,391	2,333	2,182	2,096	2,110	2,333	2,110
Common stock issued for stock-based awards	27	25	(3)	26	17	(77)
Stock compensation	50	69	61	50	69	63
Other	1			(1)
Balance, ending	2,563	2,485	2,391	2,257	2,182	2,096	2,563	2,257
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	43,846	42,860	42,051	40,780	40,227	39,898	42,051	39,898
Net income	1,947	1,931	1,753	1,353	1,380	1,174
Dividends declared and paid	(942)	(942)	(940)	(825)	(823)	(841)
Dividend equivalents on RSUs	(3)	(4)	(4)	(3)	(4)	(4)
Other	(1)	1
Balance, ending	44,847	43,846	42,860	41,305	40,780	40,227	44,847	41,305
Treasury Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	(36,596)	(36,479)	(36,578)	(36,725)	(36,002)	(34,495)	(36,578)	(34,495)
Common stock issued for stock-based awards	48	29	199	97	70	223
Stock repurchases	(139)	(146)	(100)	(15)	(793)	(1,730)
Balance, ending	(36,687)	(36,596)	(36,479)	(36,643)	(36,725)	(36,002)	(36,687)	(36,643)
AOCI
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	(323)	(347)	(360)	(334)	(328)	(347)	(360)	(347)
Other comprehensive income (loss), net of taxes	10	24	13	(1)	(6)	19
Balance, ending	$ (313)	$ (323)	$ (347)	$ (335)	$ (334)	$ (328)	$ (313)	$ (335)

Stockholders' equity - Addition

Stockholders' equity - Additional Information (Details) - $ / shares	3 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020
Equity [Abstract]
Cash dividends declared per common share (in dollars per share)	$ 1.02	$ 1.02	$ 1.02	$ 0.90	$ 0.90	$ 0.90
Cash dividends paid per common share (in dollars per share)	$ 1.02	$ 1.02	$ 1.02	$ 0.90	$ 0.90	$ 0.90

Supplemental financial inform_3

Supplemental financial information - Amounts Reclassified out of AOCI (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other income (expense), net (OI&E)		$ 15	$ 27	$ 134	$ 151
Provision for income taxes		(328)	(234)	(825)	(183)
Net income		1,947	1,353	5,631	3,907
Reclassification out of Accumulated Other Comprehensive Income \| Net actuarial losses of defined benefit plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other income (expense), net (OI&E)	[1]	10	9	31	28
Provision for income taxes		(2)	(2)	(7)	(7)
Net income		8	7	24	21
Reclassification out of Accumulated Other Comprehensive Income \| Prior service credit of defined benefit plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other income (expense), net (OI&E)	[1]	(1)	(1)	(1)	(1)
Provision for income taxes		0	0	0	0
Net income		$ (1)	$ (1)	$ (1)	$ (1)

[1]	Detailed in Note 5.

Supplemental financial inform_4

Supplemental financial information - Additional Information (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended	9 Months Ended
	Oct. 27, 2021	Sep. 30, 2021	Sep. 30, 2021
Asset Acquisition [Line Items]
Treasury shares issued related to stock compensation (in shares)		1,064,600	6,163,997
Subsequent Event
Asset Acquisition [Line Items]
Cash consideration for acquisition	$ 900